about
Human pluripotent stem cell differentiation to functional pancreatic cells for diabetes therapies: Innovations, challenges and future directions.Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.Modeling the process of human tumorigenesis.Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab-Paclitaxel Plus Gemcitabine.Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.Inspiration from heart development: Biomimetic development of functional human cardiac organoids.CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.Berries and other natural products in the pancreatic cancer chemoprevention in human clinical trials.MTOR inhibitor-based combination therapies for pancreatic cancer.Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer.Patient-derived organoid models help define personalized management of gastrointestinal cancer.Patient-derived xenografts as preclinical neuroblastoma models.New tools for old drugs: Functional genetic screens to optimize current chemotherapy.Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer.Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids.Organoids Provide an Important Window on Inflammation in Cancer.
P2860
Q33864580-E8CF06F9-855B-4897-8E3B-CC5752D0B132Q38703766-088B1EE4-EF6F-4651-8F42-4EB66EFB3A5BQ38885294-48373B08-37B9-4AB0-9D34-9ED6855B7A77Q39328610-281B95D7-3CBE-415F-8CCD-AB2E7C336363Q40162348-6D14E70E-AB87-4EA5-8FF5-C033A02DAC38Q47150223-AF36392A-E142-4824-84D4-A33C47A501B8Q47819879-99857DA9-21C3-4E76-B905-34500D032D81Q48820342-C3A0451B-59A2-4CFF-96DB-A2BE00F6C13AQ49415169-E4AFB0EE-68FA-4FDE-BF3F-4F972DB37980Q49560871-D20C23B8-B0B4-4D87-A4DF-C3E40AEE4FDBQ49804354-3360E04A-89EF-45D8-95D1-C17790D577CDQ50010294-7CBB976C-121C-4549-8689-C9E198081F66Q50027944-F6FE9FE6-359F-456E-82F9-F0DA4382CB75Q52430564-D98323FF-1256-43E3-AA15-66DE50D505A9Q52430924-B4EF4203-AB2D-4786-9449-5615AA812071Q52726462-3BCB9CAA-C905-444D-80E9-0E7BAF9A3A08Q55220021-9DF13937-C3F3-4C51-9D35-5CD5284A267BQ55302559-11224B9B-F5D1-4DD2-8AB5-089E7F360D66
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Modeling pancreatic cancer with organoids
@en
type
label
Modeling pancreatic cancer with organoids
@en
prefLabel
Modeling pancreatic cancer with organoids
@en
P2860
P1433
P1476
Modeling pancreatic cancer with organoids
@en
P2093
Hans Clevers
Lindsey A Baker
P2860
P304
P356
10.1016/J.TRECAN.2016.03.004
P577
2016-04-01T00:00:00Z